Cytophage Technologies Ltd.
CYTO.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 254.60K | 908.30K | 507.00K | 1.07M | 1.75M |
| Total Receivables | 84.40K | 69.10K | 68.90K | 142.00K | 298.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.30K | 7.40K | 7.90K | 19.90K | 6.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 68.70K | 57.80K | 55.80K | 39.60K | 63.50K |
| Total Current Assets | 414.10K | 1.04M | 639.50K | 1.27M | 2.12M |
|
|
|||||
| Total Current Assets | 414.10K | 1.04M | 639.50K | 1.27M | 2.12M |
| Net Property, Plant & Equipment | 1.87M | 1.97M | 1.99M | 2.16M | 2.43M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.28M | 3.01M | 2.63M | 3.43M | 4.54M |
|
|
|||||
| Total Accounts Payable | 303.70K | 232.00K | 218.20K | 145.20K | 154.00K |
| Total Accrued Expenses | 150.20K | 161.20K | 145.70K | 180.50K | 124.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 172.90K | 170.20K | 155.50K | 149.40K | 220.90K |
| Total Finance Division Other Current Liabilities | -- | -- | 0.00 | -- | -- |
| Total Other Current Liabilities | -- | -- | 0.00 | -- | -- |
| Total Current Liabilities | 626.90K | 563.40K | 519.40K | 475.10K | 499.30K |
|
|
|||||
| Total Current Liabilities | 626.90K | 563.40K | 519.40K | 475.10K | 499.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 819.20K | 881.80K | 879.00K | 919.60K | 955.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00 | -- | -- |
| Total Liabilities | 1.45M | 1.45M | 1.40M | 1.39M | 1.45M |
|
|
|||||
| Common Stock & APIC | 18.81M | 19.22M | 17.59M | 17.57M | 18.71M |
| Retained Earnings | -21.46M | -21.15M | -19.29M | -18.46M | -19.03M |
| Treasury Stock & Other | 3.48M | 3.50M | 2.93M | 2.93M | 3.41M |
| Total Common Equity | 837.70K | 1.56M | 1.23M | 2.04M | 3.09M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 837.70K | 1.56M | 1.23M | 2.04M | 3.09M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 837.70K | 1.56M | 1.23M | 2.04M | 3.09M |
|
|
|||||